EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudie

Comparison of the Effectiveness of Magnesium Oxide and Elobixibat on Improving Rectal Sensitivity and Colonic Transit Time in Patients With Chronic Constipation: An Observational Study

Takaomi Kessoku, Yo Ishihara, Kota Takahashi, Thanh Huy Dang, Mayumi Ohira, Mayu Horiuchi, Chiharu Shibata, Ayaka Uchida, Yukiko Toriumi, Noboru Misawa, Hidenori Ohkubo, Kento Imajo und 6 weitere

Neurogastroenterology & Motility · 2025-12 · 37 (12)

DOI: 10.1111/nmo.70106 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 24.06.2025. Verfasst von Takaomi Kessoku und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Palliative Medicine and Gastroenterology, International University Health and Welfare Narita Hospital, Chiba, Japan. Hauptthemen laut MEDLINE: Constipation, Magnesium Oxide, Gastrointestinal Transit, Rectum. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We compared the effectiveness of magnesium oxide (MgO) and elobixibat (EXB) in improving defecation desire (DD), rectal sensation, and colonic transit time (CTT) in patients with chronic constipation (CC).

Methods

This was a prospective, observational study conducted in real‐world clinical practice. We included patients with CC who met the Rome IV criteria and underwent colon transit study and rectal sensory tests ( RSTs ). Loss of defecation desire (LODD) was subjectively assessed using a questionnaire, and the rectal sensation was objectively assessed using the balloon air volume, which was measured using the first defecation desire volume (FDDV). CTT was measured using radiopaque markers, and slow transit constipation (STC) and normal transit constipation (NTC) were diagnosed using marker residual rate. The shift rate from STC at baseline to NTC after each drug administration was calculated. Drugs were selected at the discretion of the attending physician. Key Results Patients in the MgO ( n = 30) and EXB ( n = 43) groups had comparable demographic characteristics, an average prescription duration of 27 days, and average daily dosages of 1413 and 13 mg, respectively. Patients in the MgO and EXB groups showed different improvement rate of LODD (33% vs. 65%, p < 0.001), absolute changes in FDDV (−0.1 vs. 35 mL, p < 0.0001), and shift rate from STC to NTC (37% vs. 87%, p = 0.003, respectively). Conclusions and Inferences EXB demonstrated significantly greater improvements of LODD, rectal sensation, and CTT compared to MgO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ConstipationMagnesium OxideGastrointestinal TransitRectumHumansMaleFemaleMiddle AgedProspective StudiesChronic DiseaseAdultTreatment OutcomeAgedDefecationColonDipeptidesThiazepines

Stichwörter der Autor:innen

chronic constipationdefecation desireelobixibatrectal sensationslow transit constipation

Substanzen

Magnesium OxideelobixibatDipeptidesThiazepines

Autor:innen und Institutionen

  • Department of Palliative Medicine and Gastroenterology, International University Health and Welfare Narita Hospital, Chiba, Japan.
  • Department of Gastroenterology, International University Health and Welfare Graduate School of Medicine, Chiba, Japan.
  • Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Department of Internal Medicine, Yokohama Clinic, Kanagawa Dental University, Yokohama, Kanagawa, Japan.
  • Department of Nursing, International University Health and Welfare Narita Hospital, Chiba, Japan.
  • Department of Medical Technology and Sciences, School of Health Sciences at Narita, International University of Health and Welfare, Chiba, Japan.

ORCID-Profile: Tatsuya Abe, Atsushi Nakajima

Zitieren

APA

Kessoku, T., Ishihara, Y., Takahashi, K., Dang, T. H., Ohira, M., Horiuchi, M., Shibata, C., Uchida, A., Toriumi, Y., Misawa, N., Ohkubo, H., Imajo, K., Oyamada, S., Iwasaki, T., Kurihashi, T., Manabe, N., Abe, T., & Nakajima, A. (2025). Comparison of the Effectiveness of Magnesium Oxide and Elobixibat on Improving Rectal Sensitivity and Colonic Transit Time in Patients With Chronic Constipation: An Observational Study. Neurogastroenterology & Motility, 37(12). https://doi.org/10.1111/nmo.70106

Vancouver

Kessoku T, Ishihara Y, Takahashi K, Dang TH, Ohira M, Horiuchi M, et al. Comparison of the Effectiveness of Magnesium Oxide and Elobixibat on Improving Rectal Sensitivity and Colonic Transit Time in Patients With Chronic Constipation: An Observational Study. Neurogastroenterology & Motility. 2025;37(12). doi:10.1111/nmo.70106

BibTeX
@article{Kessoku2025,
  author = {Kessoku, Takaomi and Ishihara, Yo and Takahashi, Kota and Dang, Thanh Huy and Ohira, Mayumi and Horiuchi, Mayu and Shibata, Chiharu and Uchida, Ayaka and Toriumi, Yukiko and Misawa, Noboru and Ohkubo, Hidenori and Imajo, Kento and Oyamada, Shunsuke and Iwasaki, Tomoyuki and Kurihashi, Takeo and Manabe, Noriaki and Abe, Tatsuya and Nakajima, Atsushi},
  title = {Comparison of the Effectiveness of Magnesium Oxide and Elobixibat on Improving Rectal Sensitivity and Colonic Transit Time in Patients With Chronic Constipation: An Observational Study},
  journal = {Neurogastroenterology & Motility},
  year = {2025},
  volume = {37},
  number = {12},
  doi = {10.1111/nmo.70106}
}
Kostenlos starten →